# Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients

> **NCT04686760** · NA · COMPLETED · sponsor: **University of Lahore** · enrollment: 278 (actual)

## Conditions studied

- Corona Virus Infection

## Interventions

- **DRUG:** Nitroglycerin

## Key facts

- **NCT ID:** NCT04686760
- **Lead sponsor:** University of Lahore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-15
- **Primary completion:** 2021-12-15
- **Final completion:** 2022-03-15
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04686760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04686760, "Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04686760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*